Navigation Links
MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems
Date:4/18/2013

HOUSTON, April 18, 2013 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD™ linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the most advanced linear-accelerator treatments that require the greatest targeting precision. MD Anderson predicts it will be ready to treat patients on the systems by January 2014.

Versa HD is equipped with the Agility™ multileaf collimator for high-speed, high-precision beam shaping to support extremely accurate tumor targeting and improved healthy tissue preservation. With previous beam shaping technologies, high-definition (HD) beam shaping was limited to small targets. Versa HD with Agility now enables high-definition beam shaping over a significantly larger treatment field, expanding advanced treatments to a broader spectrum of tumors. Combining this novel technology with a new High Dose Rate mode, Versa HD is expected to provide rapid delivery of more sophisticated therapies within standard radiotherapy treatment times.

"To have MD Anderson employ our latest technology gives us added confidence that Elekta is providing the tools that top healthcare providers need to treat their patients," says Jay Hoey , Executive Vice President, Elekta North America .

Learn more at www.VersaHD.com.

Versa HD is not available for sale or distribution in all markets.

For further information, please contact:
Michelle Joiner , Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems
2. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
3. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
4. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
5. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
6. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
7. Une nouvelle immunothérapie anticancéreuse sur le point dentrer en phase dessais cliniques
8. Se prepara para entrar en ensayos clínicos una nueva inmunoterapia contra el cáncer
9. Novel Cancer Immunotherapy set to enter Clinical Trials
10. Study Published in European Radiology Further Supports the Use of Hologics Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads
11. Mendelsohn To Talk Personalized Cancer Therapy at Bush Library and Museum April Issues Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... December 5, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... developing promising therapeutic candidates, presents positive Phase 2a correlative data, ... leading oncology platform at the ongoing 58th American Society of ... Diego, California . ... , , As ...
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... Sideline Products is a Southern York County ... the smaller rider and the horse. Smaller saddles can pinch and irritate the horse ... fit over a properly fitted western saddle so it does not impact the comfort ...
(Date:12/5/2016)... ... ... “Life Will Never Be The Same” is a fictional tale about growing up with ... is the creation of published author, Kim T. Briggs, a self-described “big kid” who ... religion and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama ...
(Date:12/5/2016)... ... , ... Sabah Shah MD, MBA has joined the Retina Group of New York ... by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care ... of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. ...
(Date:12/5/2016)... Greifensee, Switzerland (PRWEB) , ... ... ... testing between professional calibrations is an excellent way to ensure moisture measurements ... methods are time-consuming and impractical. , Now, METTLER TOLEDO offers a ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
Breaking Medicine News(10 mins):